These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36208842)

  • 1. Long-Term Survival After Surgery Versus Ablation for Early Liver Cancer in a Large, Nationally Representative Cohort.
    Charalel RA; Mushlin AI; Li D; Mao J; Ibrahim S; Carlos RC; Kwan SW; Fortune B; Talenfeld AD; Brown RS; Madoff DC; Johnson MS; Sedrakyan A
    J Am Coll Radiol; 2022 Nov; 19(11):1213-1223. PubMed ID: 36208842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for Early Liver Cancer Survival After Ablation and Surgical Resection: A Surveillance, Epidemiology, and End Results Program-Medicare Study.
    Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos R; Brown RS; Fortune BE; Talenfeld AD; Madoff DC; Ibrahim S; Johnson MS; Sedrakyan A
    J Am Coll Radiol; 2024 Feb; 21(2):295-308. PubMed ID: 37922972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Survival: Adverse Events and Care Delivery Outcomes after Early Liver Cancer Treatment in a Nationally Representative Cohort.
    Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos RC; Brown RS; Fortune BE; Talenfeld AD; Madoff DC; Ibrahim S; Johnson MS; Sedrakyan A
    J Vasc Interv Radiol; 2023 Nov; 34(11):1997-2005.e3. PubMed ID: 37468093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison.
    Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos RC; Brown RS; Ibrahim S; Fortune BE; Talenfeld AD; Madoff DC; Johnson MS; Sedrakyan A
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431272. PubMed ID: 38899842
    [No Abstract]   [Full Text] [Related]  

  • 9. The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
    Sun X; Zhang Y; Lyu N; Li X; Chen M; Zhao M
    Med Sci Monit; 2019 Jul; 25():4941-4951. PubMed ID: 31270311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma.
    Lee J; Jin YJ; Shin SK; Kwon JH; Kim SG; Suh YJ; Jeong Y; Yu JH; Lee JW; Kwon OS; Nahm SW; Kim YS
    Clin Mol Hepatol; 2022 Apr; 28(2):207-218. PubMed ID: 34814239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of surgical resection for multiple hepatocellular carcinomas.
    Choi SH; Choi GH; Kim SU; Park JY; Joo DJ; Ju MK; Kim MS; Choi JS; Han KH; Kim SI
    World J Gastroenterol; 2013 Jan; 19(3):366-74. PubMed ID: 23372359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients.
    Ni JY; Xu LF; Sun HL; Zhou JX; Chen YT; Luo JH
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2021-33. PubMed ID: 24072235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Ablation Compared with Resection for Single Hepatocellular Carcinoma Lesions, as a Primary Treatment or Bridging to Liver Transplantation: A Retrospective Comparative Study.
    Ward EM; Sherif AE; O'Neill S; Hughes M; Ireland H; Wigmore SJ; Adair A
    Ann Transplant; 2021 Jul; 26():e931980. PubMed ID: 34326301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.